Evommune EVMN Ratios & Valuation
| TTM Q1 '26 | ||
|---|---|---|
| Profitability | ||
| Gross margin | 53.7%— | |
| Operating margin | -30.7%— | |
| Leverage | ||
| Interest coverage | -6.2×— |
Questions, answered.
- What are Evommune 's profit margins?
- Evommune (EVMN) runs a 53.7% gross margin and a -30.7% operating margin, with a -90.1% net margin.
- Where do Evommune 's ratios come from?
- Every ratio is computed from Evommune 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
